Higher levels of ADAMTS1 (OR: 1.28, 95% CI: 1.14–1.41) and ADAMTS16 (OR: 1.1, 95% CI: 1.01--1.19) were genetically predicted to be associated with lung cancer (Fig. 1C). This evidence concerns the gene ADAMTS16 and lung carcinoma.